Moreover, MB7 does not activate the receptor Na/K-ATPase/Src complex and fails to stimulate protein kinase cascades in cultured cells. Thus, we have identified a group of novel Na/K-ATPase ligands that can inhibit the pumping function without stimulating the signaling function of Na/K-ATPase.
Introduction
The Na/K-ATPase, also known as the sodium pump, is a ubiquitous trans-membrane enzyme that transports Na + and K + across the plasma membrane by hydrolyzing ATP (Blanco and Mercer, 1998; Lingrel and Kuntzweiler, 1994; Skou, 1957; Sweadner, 1989) . It belongs to the family of P-type ATPase that transits between E1
and E2 conformational states during pumping cycles. The functional enzyme is mainly composed of α and β subunits. The α subunit is the catalytic component of the holoenzyme as it contains both the nucleotide and the cation binding sites (Blanco and Mercer, 1998; Lingrel and Kuntzweiler, 1994; Sweadner, 1989) . Interestingly, studies during the past few years have uncovered many non-pumping functions of the Na/K-ATPase such as signal transduction (Aizman et al., 2001; Aydemir-Koksoy et al., 2001; Cai et al., 2008; Haas et al., 2002; Kometiani et al., 1998; Nguyen et al., 2007; Tian et al., 2006; Wang et al., 2004; Yuan et al., 2005) . Specifically, the signaling Na/K-ATPase resides in caveolae and interacts with a number of signaling proteins such as Src, the IP3 receptor and caveolin-1 (Cai et al., 2008; Tian et al., 2006; Wang et al., 2004; Yuan et al., 2005) . While the interaction between the Na/K-ATPase and the IP3 receptor facilitates Ca 2+ signaling (Tian and Xie, 2008) , the dynamic association between the Na/K-ATPase and Src regulates cellular Src activity, and makes it possible for cardiotonic steroids to stimulate protein kinase cascades ).
Cardiotonic steroids (CTS) include plant-derived digitalis drugs such as digoxin
This article has not been copyedited and formatted. The final version may differ from this version. and ouabain, and vertebrate-derived aglycones such as bufalin and marinobufagenin (MBG) (Akera and Brody, 1976; Schoner and Scheiner-Bobis, 2007) . Clinically, these steroids can be used to treat congestive heart failure because they have well-documented inotropic effects on the heart (Akera and Brody, 1976; Repke et al., 1996) . Although CTS have been considered as drugs since their discovery, recent studies have identified several of them, including ouabain and MBG, as endogenous steroids (Bagrov and Fedorova, 1998; Hamlyn et al., 1991) . It is known that the Na/K-ATPase serves as a receptor for these steroids. While binding of CTS to the Na/K-ATPase inhibits the pumping function, it stimulates the signaling function of Na/K-ATPase ). For example, binding of ouabain to the Na/K-ATPase/Src receptor complex stimulates Src kinase. The activated Src, in turn, trans-activates receptor tyrosine kinases such as the EGF receptor (EGFR) and converts the tyrosine kinase signal to stimulation of serine/threonine kinases, lipid kinases and lipases as well as increased production of reactive oxygen species (ROS) Liu et al., 2000) .
Interestingly, while inhibition of the Na/K-ATPase by CTS is essential for these drugs to increase cardiac contractile function (Altamirano et al., 2006; Reuter et al., 2002) , stimulation of protein kinases and subsequent increases in the production of ROS by these steroids also cause cardiac hypertrophy and fibrosis in animal studies (Ferrandi et al., 2004; Kennedy et al., 2006) .
Because CTS affect both ion pumping and signal transducing functions of the This article has not been copyedited and formatted. The final version may differ from this version. The purity of these compounds was above 95% unless otherwise indicated. Stock compounds were prepared in 96-well plates at 10 mg/ml in DMSO.
The purified Na/K-ATPase was prepared from pig kidney as described before (Xie et al., 1996) . The specific activities of the Na/K-ATPase of various kidney preparations were in the range of 900-1,200 μ mol/mg/h, which was greater than 95% of This article has not been copyedited and formatted. The final version may differ from this version. Western blot analysis: Cells were washed with PBS and solubilized in ice-cold RIPA buffer containing 1% Nonidet P-40, 0.25% sodium deoxycholate, 150 mM NaCl, 1 mM EDTA, 1 mM phenylmethylsulfonyl fluoride, 1 mM sodium orthovanadate, 1 mM NaF, 10 μ g/ml aprotinin, 10 μ g/ml leupeptin, and 50 mM Tris-HCl (pH 7.4) as previously described (Wang et al., 2004) . Cell lysates were then cleared by centrifugation at 14,000 rpm, and supernatants were used for protein assay and subjected to Western blot analysis. Samples were separated on SDS-PAGE (50 μ g/lane) and transferred to a cellulose membrane. Membranes were blocked with 3% non-fat dried milk for total Src and ERK or 1% BSA plus 1% non-fat dried milk for phosphorylated Src and ERK in TBST (Tris-HCl 10 mM, NaCl 150 mM, Tween 20, 0.1%; pH 7.5) for 1 h at room temperature and then probed with specific antibodies. Protein signals were detected using an ECL kit and quantified using an imaging densitometer.
Assay for the activation of receptor Na/K-ATPase/Src complex: The activity of the receptor Na/K-ATPase/Src complex was assayed as we previously described . Briefly, the purified Src (4.5 U) was incubated with 2 μ g of the purified Na/K-ATPase in PBS for 30 min at 37°C. Afterward, the Na/K-ATPase/Src complex was exposed to ouabain or MB7 for 10 min. Reaction was initiated by addition of 2 mM ATP/Mg 2+ , continued for 5 min at 37°C, and stopped by addition of the SDS sample buffer. The activation of Src was measured by Western blot using the anti-pY418
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RESULTS
High throughput screening of Na/K-ATPase inhibitors: To screen a chemical library for Na/K-ATPase inhibitors, we developed a 96-well format assay. As depicted in Fig. 1A , ouabain, as a positive control, produced a dose-dependent inhibition of the Na/K-ATPase. On the other hand, DMSO, the vehicle, showed no effect on Na/K-ATPase activity when used at a concentration below 0.1% of reaction volume (data not shown). The apparent IC 50 for ouabain was about 1 μ M, comparable to what was reported (Bottinger and Habermann, 1984) . Thus, we used the same assay and tested a total of 2600 compounds at the final concentration of 10 μ g/ml. This concentration was adapted because a majority of compounds has a molecular mass around 200, thus being adopted around 50 μ M, 50 times the IC 50 of ouabain. Ouabain (5 μ M) was used as a positive control whereas 0.1% DMSO was used as a negative control in each 96-well plate. Assays were conducted in duplicate, and the compound that produced 25% or more inhibition of the Na/K-ATPase was identified as a positive hit. Under these experimental conditions, we found and confirmed a total of 13 positive compounds (Table 1 ) that include several well-known Na/K-ATPase inhibitors such as oligomycin and cardiotonic steroids.
Identification of hydroxyxanthones as a new class of Na/K-ATPase ligands:
Among the thirteen positive hits, many are polyphenolic compounds including six This article has not been copyedited and formatted. The final version may differ from this version. hydroxyl xanthone derivatives (MB1 to MB7) (Table 1 ). Structurally, they are similar to the well-characterized polyphenolic compounds such as quercetin (Fig. 1B) (Kuriki and Racker, 1976; Robinson et al., 1984) . Thus, we further explored the inhibitory properties of these hydroxyxanthones. Because MB7 was the most potent inhibitor of this group (Table 2) , it was used in the following studies. In experiments depicted in Fig. 1A , we compared the dose-response curves of MB7, ouabain and quercetin. Like ouabain, MB7 exhibited dose-dependent inhibition of the Na/K-ATPase. The apparent IC 50 (1.6 ± 0.1 μ M) is comparable to that of ouabain. In comparison, quercetin is less effective as an inhibitor of Na/K-ATPase. Unlike ouabain and MB7, it only produced a partial inhibition of the Na/K-ATPase. The maximal inhibition was achieved when 5
μM quercetin was applied (Kuriki and Racker, 1976) .
To determine whether MB7 produces a reversible inhibition of Na,K-ATPase, the purified Na,K-ATPase was treated with 10 μ M MB7 at 37°C for 15 min, washed twice by centrifugation, resuspended, then assayed for Na/K-ATPase activity. After washed enzyme was incubated in assay medium for 15 and 60 min, the recovery of the activity reached s % and 94s%, respectively.
To explore whether MB7 inhibits the Na/K-ATPase by altering substrate affinity, we measured the Na/K-ATPase as a function of substrate concentration in the presence or the absence of MB7. As shown in Fig. 2 , MB7 had no effect on either Na + or ATP This article has not been copyedited and formatted. The final version may differ from this version. affinity of the Na/K-ATPase. Interestingly, increases in K + failed to antagonize MB7-induced inhibition of the Na/K-ATPase (Fig. 2B) , which is in contrast to ouabain-induced inhibition (Myers et al., 1979) . Since MB7 and quercetin are both polyphenolic compounds, we further explored the effect of DMSO on MB7-induced inhibition of Na/K-ATPase. It is known that high concentrations of DMSO inhibit Na/K-ATPase by stabilizing the enzyme at the E2 conformation, which antagonizes the inhibitory effect of quercetin on the Na/K-ATPase (Foster and Ahmed, 1982; Robinson et al., 1984) . Indeed, as shown in Table 3 , DMSO produced a dose-dependent inhibition of Na/K-ATPase. Under such conditions, the maximal effect of 10 μ M quercetin on the Na/K-ATPase was significantly reduced. For example, addition of 5% DMSO abolished the inhibitory effect of quercetin (Table 3) . On the other hand, the inhibitory effect of 5 μM MB7 on the Na/K-ATPase was not affected by DMSO.
To explore the structure-activity relationship, we compared the dose-response curves of xanthone, six hydroxyxanthones and several methylated hydroxyxanthone derivatives. As depicted in Table 2 , while xanthone failed to inhibit Na/K-ATPase activity, an increase in the number of phenolic groups increased the efficacy and potency of hydroxyxanthones (e.g., comparing MB2 with MB5). Consistently, full or partial methylation was able to reduce the inhibitory effect of hydroxyxanthones on the Na/K-ATPase (e.g., comparing MB5 with MB8). Finally, it appears that when phenolic groups were positioned near the oxygen in the pyrone ring (i.e., at position 4 and 5), they
This article has not been copyedited and formatted. The final version may differ from this version. Na/K-ATPase, was effective in stimulating the Na/K-ATPase-associated Src (Fig. 3) , we tested the effect of 1 and 10 μ M MB7. At such concentrations, MB7 would produce 31 and 100% inhibition of Na/K-ATPase (Fig. 2) . As depicted in Fig. 3 , addition of MB7 failed to stimulate Na/K-ATPase-associated Src in the test tube. These findings suggest that MB7 may inhibit the ATPase activity without stimulating the receptor function of Na/K-ATPase.
To verify the above findings, we measured the effect of MB7 on Src and ERKs in cascade in LLC-PK1 cells (Haas et al., 2002; Tian et al., 2006) . Indeed, we found that ouabain increased the cellular amount of active ERKs as detected by immunostaining (Fig. 4B) . However, under the same experimental conditions, MB7 (from 0.1 to 10
failed to affect cellular ERK activity.
DISCUSSION
In this study, we adapted a simple but effective high throughput screen assay and identified 13 Na/K-ATPase inhibitors that represent several structurally divergent classes of compounds. Moreover, we were able to differentiate the newly identified inhibitors from other known inhibitors such as ouabain by assessing their effects on substrate dependence of the Na/K-ATPase. Finally, we found that the newly identified xanthone derivatives, unlike ouabain, only inhibit the ATPase activity, but do not activate the receptor Na/K-ATPase/Src complex. Thus, we have identified a new class of Na/K-ATPase ligands.
Xanthone derivatives as a new class of Na/K-ATPase inhibitors: According to the Albers-Post reaction scheme, the Na/K-ATPase transits from the E1 to the E2 state via multiple conformational changes. While Na + favors the E1 state, K + promotes the conversion of E2P to the E2 state. Over the years, several classes of organic Na/K-ATPase inhibitors have been identified (Fahn et al., 1966; Yoda and Yoda, 1982) .
They inhibit the Na/K-ATPase by stabilizing the enzyme at different conformational states. For example, ouabain binds and stabilizes the Na/K-ATPase at the E2P.
Increases in K + compete with the binding of ouabain to the Na/K-ATPase and reduce ouabain-induced inhibition. In contrast, K + fails to antagonize the inhibitory effect of MB7 on the Na/K-ATPase.
This article has not been copyedited and formatted. The final version may differ from this version. Hydroxyxanthones and flavonoids have similar chemical structures since they both contain the benzopyrone structure (Fig. 1B) . Moreover, quercetin and myricetin are well known Na/K-ATPase inhibitors (Suolinna et al., 1975) . However, unlike MB7, quercetin only produces a partial inhibition of Na/K-ATPase (Fig. 1) . Mechanistically, stabilization of Na/K-ATPase by DMSO at E2 conformation blocks quercetin (Robinson et al., 1984) , but not MB7-induced inhibition of Na/K-ATPase (Table 3) . Thus, the fusion of a benzene ring to benzopyrone may alter the characteristics of interaction between hydroxyxanthones and the Na/K-ATPase.
Structually, the data presented in Table 2 point out the importance of phenolic groups in xanthone derivative-induced inhibition of the Na/K-ATPase. The parent compound xanthone has no phenolic group attached to benzene rings and it had no detectable inhibition of the Na/K-ATPase. While tetrahydroxyxanthone (MB7) is the most potent inhibitor, dihydroxyxanthones barely affect the ATPase activity. Moreover, the position of phenolic groups also affects the potency of the compounds. For example, while both MB7 and MB6 contain 4 phenolic groups, MB7 is more potent than that of MB6.
Because the Na/K-ATPase shares many common features with other P-type ATPases, it is possible that the newly identified xanthone derivatives may also affect other ion pumps. This issue remains to be resolved. In addition, it would be of interest Na/K-ATPase inhibitors working through a different mechanism.
MB7 does not activate the receptor Na/K-ATPase/Src complex: We have demonstrated that the Na/K-ATPase binds Src both in vitro and in vivo (Chen et al., 2009; Liang et al., 2006) . This association regulates cellular Src activity by keeping Src in an inactive state . Moreover, formation of the Na/K-ATPase/Src complex produces a functional receptor for ouabain to stimulate the pump-associated Src, which subsequently assembles and activates multiple downstream protein kinase cascades including the ERKs. In contrast to ouabain, binding of MB7 to the Na/K-ATPase/Src complex in vitro failed to activate Src (Fig. 3) . Consistently, it had no effect on cellular Src and ERK activity when MB7 was applied to cultured cells (Fig.   4 ). These findings indicate that MB7, unlike ouabain, fails to alter conformation of the Na/K-ATPase in a way so that the Src kinase domain can be released from the Na/K-ATPase. This is not surprising because MB7 inhibits the Na/K-ATPase in a different way from that of ouabain. As discussed above, many types of inhibitors have been identified over the years. In view of our new findings, it would be of great interest to test how other Na/K-ATPase inhibitors such as oligomycin and quercetin affect receptor function of the Na/K-ATPase.
Perspectives: The name xanthone designates a group of secondary metabolites normally found in a small group of plants, fungi and lichens. The xanthones from plants (Morimura, 2003; Yong Jiang, 2001) . As phenolic compounds, xanthones have been described for their antioxidant properties (Minami et al., 1995; Sato et al., 1992; Wang et al., 1997) . These properties have been implicated in their anti-inflammatory and chemopreventive actions (Pinto et al., 2005) . One of the xanthones, dimethylxanthenone-4-acetic acid, is currently undergoing clinical trials as an antitumor agent (McKeage et al., 2009) . Based on our new findings, it will be of great interest to test whether MB7 is able to increase cardiac contractile function. If this can be demonstrated, these hydroxyxanthones could be of great value because they do not stimulate the receptor Na/K-ATPase/Src complex. It has been well-documented in the literature that stimulation of Na/K-ATPase-mediated signal transduction by either endogenous or exogenous CTS alters cardiac growth and induces cardiac fibrosis (Ferrandi et al., 2004; Kennedy et al., 2006) . Therefore, MB7 and its analogs may improve contractile function without precipitating cardiac hypertrophy and fibrosis seen under clinical conditions of congestive heart failure. This article has not been copyedited and formatted. The final version may differ from this version. *These inhibitors produced at least 25% inhibition of Na/K-ATPase at 10 μg/ml.
